Sector: Health Care
Director information for NATERA INC (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Dr. Bertagnolli | Director | ["Audit committee financial expert"] | ["Nominating, Corporate Governance and Compliance Committee"] | 2026 | |
| Dr. Marcus | Chair of the Nominating, Corporate Governance and Compliance Committee | [] | ["Nominating, Corporate Governance and Compliance Committee"] | 2026 | |
| Dr. Rubin | Director | [] | ["Nominating, Corporate Governance and Compliance Committee"] | 2026 | |
| Drs. Baynes | [] | ["Nominating, Corporate Governance and Compliance Committee"] | 2026 | ||
| Eric H. Rubin | Director | 67 | ["physician-scientist","biotechnology executive","over 35 years of experience in oncology drug development","former faculty member at the Dana-Farber Cancer Institute","former senior leader of the Cancer Institute of New Jersey","served as Director of Investigational Therapeutics Division","held roles at Merck & Co., Inc.","contributed to advancement of multiple oncology programs","member of National Cancer Institute and American Cancer Society study sections","co-chair of Cancer Steering Committee of the Biomarkers Consortium"] | ["Nominating","Corporate Governance and Compliance"] | 2026 |
| Gail Marcus | Director | 69 | ["Assistant professor of health professions at Hofstra University","Former assistant professor and director of Global Healthcare Management and Biomedical Informatics programs","Former department chair of Pharmaceutical Business and Administrative Services at Massachusetts College of Pharmacy and Health Sciences","Former consultant and practice leader in healthcare consulting","Former CEO and president of Calloway Laboratories","Leadership roles in diagnostics, pharmacy benefit management, and managed care","Board member of private biotechnology companies","CERT Certificate in Cybersecurity Oversight from Carnegie Mellon University","Bachelor of Arts in Spanish and Mathematics from Wesleyan University","M.S.E. in Computer and Information Sciences from the University of Pennsylvania","M.B.A. from the Wharton School of the University of Pennsylvania","Doctorate of Health Administration from the Medical University of South Carolina"] | ["C","Nominating, Corporate Governance and Compliance (chair)","Audit"] | 2026 |
| Herm Rosenman | Director | 78 | ["B.B.A. in Accounting and Finance from Pace University","M.B.A. in Finance from the Wharton School of the University of Pennsylvania","Experience as Chief Financial Officer","Experience in the biopharmaceutical industry","Experience serving on the boards of other companies"] | ["C","Audit","Human Capital"] | 2026 |
| Jonathan Sheena | Co-Founder and Director | 53 | ["Co-founder of the company","Former Chief Technology Officer","Experience with entrepreneurial companies","Familiarity with technology companies"] | [] | 2026 |
| Matthew Rabinowitz | Co-Founder and Executive Chairman of the Board | 53 | [] | [] | 2026 |
| Matthew Rabinowitz, Ph.D | Co-Founder | 53 | ["Co-Founder of the company","Former Chief Executive Officer from 2005 to January 2019","Chairman of the board of directors from May 2015 to January 2019","Experience as chief executive officer and chief technology officer of Rosum Corporation","Consulting professor at Stanford University from 2004 to 2012","Visiting faculty at Harvard University from 2018 to 2019","Authored over 100 patents and publications in signal processing, machine learning, bio-informatics, and high-throughput genetic testing","Received the Scott Helt Memorial Award from the IEEE","Two companies founded received the Technology Pioneer Award from the World Economic Forum","Named a Precision Medicine World Congress Luminary for 2025","R&D Leader of the Year 2024 by R&D World","Board member or advisory board member for private technology companies","Holds a Bachelor of Science degree in Engineering and Physics, a Master of Science in Electrical Engineering, and a Ph.D. in Electrical Engineering from Stanford University"] | [] | 2026 |
| Monica Bertagnolli | Director | 67 | [] | [] | 2026 |
| Monica Bertagnolli, M.D. | Director | 67 | ["Wilson Professor of Surgery in the field of oncology emerita at Harvard Medical School","senior fellow in healthcare policy at the Harvard Kennedy School of Government","held various professor of surgery roles at Harvard Medical School from 1999-2022","associate surgeon in the Surgical Oncology division at Brigham and Women’s Hospital and Dana-Farber Cancer Institute","chief of the Surgical Oncology division from 2008-2018","chair of the board of directors of the American Society of Clinical Oncology (ASCO) from 2020-2021","group chair and president of the Alliance for Clinical Trials in Oncology Foundation from 2011-2022","chief executive officer of Alliance Foundation Trials, LLC from 2014-2022","served on the board of directors of the American Cancer Society from 2020-2022","served on the board of Prevent Cancer from 2018-2022","served on the board of Leap Therapeutics from 2018-2022","extensive clinical experience in oncology"] | ["Nominating","Corporate Governance and Compliance"] | 2026 |
| Roelof F. Botha | Lead Independent Director | 52 | ["Partner at Sequoia Capital","Chief Financial Officer at PayPal, Inc.","Board member of Block, Inc.","Board member of MongoDB, Inc.","Board member of Unity, Inc.","Previous board member of 23andme","Previous board member of Bird Global","Previous board member of Eventbrite, Inc.","Bachelor of Science in Actuarial Science, Economics, and Statistics from the University of Cape Town","M.B.A. from Stanford University","Financial and managerial experience"] | ["Nominating","Corporate Governance and Compliance","Nominating, Corporate Governance and Compliance Committee"] | 2026 |
| Rowan Chapman | Director | 55 | [] | ["C"] | 2026 |
| Rowan Chapman, Ph.D. | Director | 55 | ["co-founder of and advisor to Initiate Studios","advisor to BEVC","adjunct lecturer at Stanford University","chief business officer of Dynamics Special Purpose Corporation","head of Johnson & Johnson Innovation, Western North America, Australia and New Zealand","various roles with General Electric Company","partner at Mohr Davidow Ventures","NACD Directorship Certified"] | ["Human Capital","Audit"] | 2026 |
| Roy Baynes | Director | 71 | [] | [] | 2026 |
| Roy Baynes, M.D., Ph.D. | Director | 71 | ["extensive experience in the biopharmaceutical industry","experience on other public company boards of directors","M.D. and a Ph.D. from the University of the Witwatersrand, Johannesburg, South Africa"] | ["Nominating","Corporate Governance and Compliance"] | 2026 |
| Ruth Williams-Brinkley | Director | 73 | ["joined our board of directors in March 2023","formed RWB Advisory Services to focus on consulting and advisory services to healthcare organizations","served as regional president of Kaiser Foundation Health Plan of the Mid-Atlantic States","president of Kaiser Foundation Health Plan and Hospitals of the Northwest from November 2017 to June 2020","president and chief executive officer of KentuckyOne Health","president and chief executive officer of Carondelet Health Network","president and chief executive officer of Memorial Health Care System","corporate system vice president at CommonSpirit Health","served on the board of directors of Travere Therapeutics, Inc.","currently serves on the board of directors of University of Phoenix and a number of not for profit organizations","previously served as a member of the Board of Directors of Results Physiotherapy and Chattem, Inc.","held various nursing staff and management roles"] | ["Human Capital"] | 2026 |
| Steven L. Chapman | Chief Executive Officer, President and Director; Chief Executive Officer and Director | 46 | ["CEO since January 2019","Former Chief Operating Officer","Experience in the biotechnology field","Researcher in human genetics at UCLA","Co-author of scientific papers in reproductive health and organ health","Bachelor of Science in Microbiology, Immunology and Molecular Genetics from UCLA"] | ["American Clinical Laboratories Association (ACLA)"] | 2026 |
